Business Standard

Piramal Enterprises gets shareholders' nod to demerge pharma business

The company has received 99 per cent of votes at the shareholders meeting held on Tuesday, PEL said in a statement

Piramal Ent
Premium

Piramal Enterprises

BS Reporter
Ajay Piramal-owned Piramal Enterprises has received shareholders’ approval to  demerge its pharmaceuticals business and simplify the corporate structure.

The company has received 99 per cent of votes at the  shareholders meeting held on Tuesday, PEL said in a statement.

The demerger will divide the  company into two focused entities —financial services and pharmaceuticals.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in